Cardiac Mapping Market Expected to Reach $4.6 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Cardiac Mapping Market," The cardiac mapping market size was valued at $2.6 billion in 2021, and is estimated to reach $4.6 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031.

Cardiac mapping is an electrophysiology study that determines the causes behind the heart rhythm problem, such as arrhythmia and is used widely for identification, characterization, and localization of an arrhythmia. Mapping the electrical activity of the heart is a critical component for the diagnosis and treatment of heart disease and many advanced therapies require detail mapping.

According to the National Center for Biotechnology Information (NCBI), atrial fibrillation is the most frequent cardiac arrhythmia and is estimated that 6-12 million people globally are to suffer this condition in the U.S. by 2050 and 17.9 million people in Europe by 2060. Also, people of European descent are more likely to have atrial fibrillation than African Americans. Thus, this rise in the number of the cardiovascular disease cases around the globe with rise in the number of the geriatric patients, leads to the growth of the cardiac mapping industry.

Furthermore, factors such as increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in developing regions, high incidence of cardiovascular diseases, growing focus of government organizations on providing funding for research, and increasing awareness about the treatment options for the cardiovascular diseases accelerate the cardiac mapping market growth.

However, the high cost of the cardiac mapping systems is the major restraining factor of cardiac mapping market. In addition, lack of the well trained and experienced electrophysiologists are the factors which negatively affects the growth of the market.

According to the product, the contact cardiac mapping systems dominated the market segment in the year 2021, due to the advantage offered by contact cardiac mapping, such as they allow the accurate placement of mapping and ablation catheters in a three-dimensional environment. Additionally, with a multi-electrode basket catheter, recording in just a few beats may be possible and is sufficient to recognize the arrhythmia circuit. On the contrary, the non-contact cardiac mapping systems segment is expected to grow at a highest CAGR during the forecast period.

By indication, the atrial fibrillation segment holds a dominating position in the global cardiac mapping market in 2021, whereas the atrial flutter segment is expected to grow at the fastest rate at a CAGR during the forecast period owning to the rise in the prevalence of the arterial flutter cases by damage in the heart resulting from prior cardiac disease or heart surgery.

By end user, in cardiac mapping market trends, the hospitals segment held the largest share of the market in 2021, because of large number of hospitalization and visit cases registered due to the rise in the number of the cardiac disorders, and due to the presence of the well trained cardiac electro physiologist that specializes in diagnosing and treating abnormal heart rhythms in the developed countries. Furthermore, the same segment is also expected to grow at the highest CAGR during the forecast period.

Region-wise, North America has the highest cardiac mapping market share in 2021, owing to development of new technologies, increasing prevalence of chronic heart diseases, the adoption of cardiac mapping systems by major hospitals. However, Asia-Pacific is expected to exhibit highest CAGR during the forecast period, increased in funding by government of various countries in Asia-Pacific region to advance healthcare infrastructure.

KEY FINDINGS OF THE STUDY

• By product, the contact cardiac mapping systems segment was the highest contributor to the market in 2021.
• By indication, the atrial fibrillation segment was the highest contributor to the market in 2021, whereas the atrial flutter segment is expected to grow at the highest CAGR during the forecast period.
• By end user, the hospital segment was highest contributor in 2021.
• Region-wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.